Impact of Antibiotic Consumption on Antimicrobial Resistance to Invasive Hospital Pathogens
- PMID: 36830170
- PMCID: PMC9952588
- DOI: 10.3390/antibiotics12020259
Impact of Antibiotic Consumption on Antimicrobial Resistance to Invasive Hospital Pathogens
Abstract
The aim of our investigation is to correlate the wholesale data on antibiotic consumption expressed in daily doses per 1000 inhabitants per day (DID) with the resistance rate of invasive pathogen bacteria from 2017 to 2021. The data on antimicrobial resistance were collected from an analysis of the primary isolates of hospitalized patients. According to the CAESAR manual, the selected pathogens isolated from blood culture and cerebrospinal fluids were tested. The consumption of antibiotics for systematic use showed a statistically significant increasing trend (β = 0.982, p = 0.003) from 21.3 DID in 2017 to 34.5 DID in 2021. The ratio of the utilization of broad-spectrum to narrow-spectrum antibiotics increased by 16% (β = 0.530, p = 0.358). The most consumed antibiotic in 2021 was azithromycin (15% of total consumption), followed by levofloxacin (13%) and cefixime (12%). A statistically positive significant correlation was discovered between the percentage of resistant isolates of K. pneumoniae and consumption of meropenem (r = 0.950; p = 0.013), ertapenem (r = 0.929; p = 0.022), ceftriaxone (r = 0.924; p = 0.025) and levofloxacin (r = 0.983; p = 0.003). Additionally, the percentage of resistant isolates of E. coli and consumption of ertapenem showed significant correlation (r = 0.955; p = 0.011). Significant correlation with consumption of the antibiotics widely used at the community level, such as levofloxacin, and resistance isolated in hospitals indicates that hospital stewardship is unlikely to be effective without a reduction in antibiotic misuse at the community level.
Keywords: antibiotics; consumption; pathogen; resistance.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Rizk N.A., Moghnieh R., Haddad N., Rebeiz M.C., Zeenny R.M., Hindy J.R., Orlando G., Kanj S.S. Challenges to Antimicrobial Stewardship in the Countries of the Arab League: Concerns of Worsening Resistance during the COVID-19 Pandemic and Proposed Solutions. Antibiotics. 2021;10:1320. doi: 10.3390/antibiotics10111320. - DOI - PMC - PubMed
-
- WHO Regional Office for Europe Antimicrobial Medicines Consumption (AMC) Network: AMC Data 2014–2018. [(accessed on 15 November 2022)]. Available online: https://apps.who.int/iris/bitstream/handle/10665/342930/9789289055567-en....
-
- Šuljagić V., Bajčetić M., Mioljević V., Dragovac G., Mijović B., Janićijević I., Đorđević Z., Krtinić G., Rakić V., Ćirković I., et al. A nationwide assessment of the burden of healthcare-associated infections and antimicrobial use among surgical patients: Results from Serbian point prevalence survey, 2017. Antimicrob. Resist. Infect. Control. 2021;10:47. doi: 10.1186/s13756-021-00889-9. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
